Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Operating Margin (2016 - 2025)

Cytokinetics (CYTK) has disclosed Operating Margin for 16 consecutive years, with 248.64% as the latest value for Q4 2025.

  • Quarterly Operating Margin changed N/A to 248.64% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 413.93% through Dec 2025, changed N/A year-over-year, with the annual reading at 695.44% for FY2025, 211781.0% down from the prior year.
  • Operating Margin for Q4 2025 was 248.64% at Cytokinetics, up from 8613.38% in the prior quarter.
  • The five-year high for Operating Margin was 12.22% in Q2 2022, with the low at 52277.91% in Q2 2024.
  • Average Operating Margin over 5 years is 10258.15%, with a median of 6491.06% recorded in 2022.
  • The sharpest move saw Operating Margin tumbled -3820075bps in 2024, then soared 5211091bps in 2025.
  • Over 5 years, Operating Margin stood at 54.16% in 2021, then crashed by -11884bps to 6491.06% in 2022, then decreased by -17bps to 7620.69% in 2023, then crashed by -299bps to 30410.58% in 2024, then soared by 99bps to 248.64% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods came in at 248.64%, 8613.38%, and 167.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.